FDA Approves Remicade for Children with Crohn s Disease Remicade is
FDA Approves Remicade for Children with Crohn s Disease
Remicade is a genetically engineered monoclonal antibody, which reduces inflammation (swelling/redness) by blocking the action of tumor necrosis factor-alpha (TNF- ), that was initially approved in 1998 to treat Crohn's disease in adults.